Abstract

Neurotoxicity caused by nonfibrillar amyloid β (Aβ) oligomers in the brain is suggested to be associated with the onset of Alzheimer's disease (AD). Elucidating the structural features of Aβ oligomers is critical for promoting drug discovery research for AD. One of the Aβ oligomers, known as Aβ*56, is a dodecamer that impairs memory when injected into healthy rats, suggesting that Aβ*56 may contribute to cognitive deficits in AD patients. Another dodecamer structure, formed by 20-residue peptide segments derived from the Aβ peptide (Aβ17-36), has been revealed by X-ray crystallography. The structure of the Aβ17-36 dodecamer is composed of trimer units and shows the oligomer antibody A11 reactivity, which are characteristic of Aβ*56, indicating that Aβ*56 and the Aβ17-36 dodecamer share a similar structure. However, the structure of the C-terminal regions (Aβ37-42) remains unclear. The C-terminal region, which is abundant in hydrophobic residues, is thought to play a key role in stabilizing the oligomer structure by forming a hydrophobic core. In this study, we employed dissipative particle dynamics, a coarse-grained simulation method with soft core potentials, utilizing the crystal structure information to unravel Aβ dodecamer structures with C-terminal regions. The simulation results were validated by the reported experimental data. Hence, an analysis of the simulation results can provide structural insights into Aβ oligomers. Our simulations revealed the stabilization mechanism of the dodecamer structure at the molecular level. We showed that C-terminal regions spontaneously form a hydrophobic core in the central cavity, contributing to stabilizing the dodecamer structure. Furthermore, four consecutive hydrophobic residues in the C-terminal region (i.e., Val39-Ala42) are important for core formation.

Highlights

  • The development of drug therapies and diagnostic tools for Alzheimer’s disease (AD) has been vigorously explored, and structural information concerning probable target proteins is actively being investigated

  • We first evaluated the ability of dissipative particle dynamics (DPD) simulations to reproduce the crystal structure of the Aβ17−36 dodecamer (Figure 1A).[29]

  • After placing the Aβ17−36 dodecamer in a box filled with coarse-grained water (W) beads, as shown in Figure 3A, we performed 250 × 103-step DPD simulations

Read more

Summary

Introduction

The development of drug therapies and diagnostic tools for Alzheimer’s disease (AD) has been vigorously explored, and structural information concerning probable target proteins is actively being investigated. The presence of Aβ plaques, insoluble Aβ fibrils in the brain, is an important indicator of AD onset according to the amyloid cascade hypothesis.[1] this hypothesis is hampered by several contradictions with clinical observations, such as the weak correlation between Aβ plaques in the brain and cognitive deficits in patients with AD.[2]. In addition to insoluble Aβ fibrils, Aβ peptides can develop soluble forms. In 1996, soluble Aβ dimers and trimers were isolated from AD brains,[3] and thereafter, various

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.